KFDA to enforce tough penalty against drugs recalls.

The KFDA explained about the new provision that would be enforced from March next year in the meeting of "the recall for the drugs of no quality test pass" at KPMA on Nov. 2 that the company should be penalized with one month business suspension if the company failed to recall the drugs of no quality acceptance.

In the meeting the regulatory agency stressed to say that the company should be ...